. Adiposity (waist circumference and body fat) is strongly inversely associated with plasma LA accounting for 11.8% of variance observed, which is followed by FADS1/2 haplotypes (3.9%), quantity and quality of carbohydrate intakes (3.8%), dietary PUFA intakes (3.7%), systolic blood pressure (3.6%), and age (3.2%). Conclusion: Plasma LA is inversely associated with adiposity, followed by haplotypes of FADS1/2 genes, carbohydrate intakes, and dietary PUFA intakes. The association observed between plasma LA and adiposity may be linked to decreased de novo lipogenesis, insulin resistance, and inflammation.
Introduction
The essential fatty acid, dietary linoleic acid (LA) has traditionally been considered as protective against cardiovascular disease (CVD) [1] and coronary heart disease. [2, 3] Randomized controlled trials suggest that diets high in PUFA may result in lower fat DOI: 10.1002/mnfr.201700785 accumulation relative to other fatty acids. [4, 5] A number of observational studies have also attempted to relate circulating or plasma LA to health outcomes. In healthy adults, two recent studies which completed pattern analysis of a suite of plasma and erythrocyte fatty acids identified patterns rich in LA, both of which were associated with healthier phenotypes. [6, 7] The Epic Interact Study reported a strong inverse association between plasma linoleic acid and type 2 diabetes incidence. [8] Other studies in older populations or those at risk of CVD have suggested that circulating LA is inversely related to adiposity, [9, 10] central adiposity [5, 11] and risk of the metabolic syndrome and type 2 diabetes, but not coronary heart disease. [12, 13] In a middleaged community cohort, half of whom were obese, erythrocyte LA was inversely related with insulin resistance measured by homeostatic model assessment (HOMA) score and IL-6. [11] However, any relationship between plasma LA and health may be influenced by body weight status, with initial reports suggesting that circulating LA is positively related to circulating concentrations of soluble intercellular adhesion molecule-1 ( a marker of endothelial activation and predictor of future CVD events) in obese participants, the opposite being observed for normal weight adults. [6] Beyond this, little is known in terms of to what extent circulating LA level is associated with adiposity and how www.advancedsciencenews.com www.mnf-journal.com circulating LA is related to other markers of inflammation and metabolic health, particularly in younger, healthy cohorts.
The enzymes -5 and -6 desaturase, encoded by fatty acid desaturase (FADS) 1 and 2 genes, are the rate limiting enzymes regulating synthesis of long-chain n-6 PUFAs, such as the conversion of LA to γ -linoleic acid (GLA, 18:3n-6), dihomo-γ -linoleic acid (DGLA, 20:3n-6), and arachidonic acid (ARA, 20:4n-6). Using genotype and haplotype analysis, circulating LA levels were associated with FADS 1 and 2 genes, [14] [15] [16] with carriers of minor alleles demonstrating increased circulating LA. [17] Generally, the interaction between adiposity, dietary intakes, circulating LA, and haplotypes of FADS1/2 genes and how any interaction may affect markers of inflammation and risk of metabolic syndrome (MetS) remain largely unknown. Against this backdrop, the objective of present study was to explore, in a cohort of healthy Irish adults, the association between plasma LA and adiposity, demographics, dietary intakes, and haplotypes of FADS1/2 genes.
Experimental Section

Design and Population
This paper uses data from the cross-sectional national food survey of Irish adults: the National Adult Nutrition Survey (NANS). [18] The NANS (May 2008-April 2010) examined the habitual food and beverage intake of a representative sample (n = 1500; 740 males and 760 females) of Irish adults aged 18-90 years who were free living and who were not pregnant or breast feeding. Ethical approval was obtained from University College Cork Clinical Research Ethics Committee of the Cork Teaching Hospitals and the Human Ethics Research Committee of University College Dublin (ECM 3 (p) September 4th, 2008). All procedures in this study were in accordance with the guidelines laid down in the Declaration of Helsinki, with written informed consent obtained from all participants.
As no national identification system exists in the Republic of Ireland, hence participants were randomly selected from the Data Ireland (National Postal Service) database of free-living adults in Ireland in 20 geographical clusters nationwide, with clusters selected to provide proportional representation across the urbanrural continuum and a minimum of 100 participants in the least populated age and sex subgroups. A sample of 1500 free-living adults, representing the Irish population of over 4 million people participated in the dietary survey with analyses of the profile of NANS showing it to be representative of adults in Ireland with respect to age, gender, social class, and urban/rural location compared to the most recent Irish census. [18] [19] [20] The overall response rate was 60%. In the present paper, only participants for whom fatty acid profiles were available and valid reporters were included, leaving a final sample size of 820 (which remained representative of the entire cohort). Demographics of participants who provided fasting blood samples are reported elsewhere. [20] 
Dietary Assessment
Food and beverage consumption was assessed using a 4-day semi-weighed food record. Initial nutrient analysis was carried out using the Weighed Intake Software Program (Tinuviel Software, Anglesey, UK), which uses data from McCance & Widdowson's The Composition of Foods, fifth and sixth editions plus all nine supplemental volumes as described elsewhere [18] to generate nutrient intake data. Adjustments were made to the food composition database to take account of recipes, nutritional supplements, commonly consumed generic Irish food, and new foods on the market. All entries were double checked by the researcher and a random sample was checked by another researcher inhouse to minimize the chance of error.
Plasma Fatty Acids Analysis
The procedures used to determine plasma fatty acid profiles in the fasted samples are described elsewhere. [6] In brief, plasma lipids were extracted using the method of Bligh and Dyer. [21] Butylated hydroxytoluene and heptadecanoic acid (2 mg mL −1 in methanol) were used as antioxidant and internal standard, respectively. Extracted plasma lipids were transesterified using boron tri-fluoride-methanol solution (14%), and the resulting fatty acid methyl esters were extracted twice using hexane and water. [22] Fatty acid methyl esters were separated and identified by GC-MS HP 5890 Series II, HP 5971A (Hewlett Packard) using an Omegawax 250 fused silica capilary column (30 m × 0.25 mm × 0.25 μm film thickness; Supelco). Overall, 38 known peaks were identified (including 17:0 as internal standard) using GC-MS. Laboratory coefficient of variation (CV) of LA in fasting blood samples was 14.4%. The demographics of participants who provided a blood sample (76% of total sample), and those in the entire sample have been reported elsewhere, with no significant differences identified. [19] 
Assessment of Biochemical Profiles and Metabolic Risk Factors
Collection of anthropometric measurements (including weighed body weight, BMI, waist circumference, body fat, and blood pressure) and biochemistry parameters assessment has been described elsewhere. [23, 24] In brief, anthropometric measurements were carried out in duplicate by trained researchers using standardized methods. % Body fat and weight were collected using Tanita Model BC-420 MA body composition analyzers (Tanita Ltd. GB) with a %CV of 0.73 and 0.02%, respectively. Height was measured using a Leicester portable height measure (Seca, Birmingham, UK). All scales were calibrated and placed on a hard surface prior to use with participants asked to remove any heavy clothing, accessories, or shoes as appropriate. Hip and waist circumference were measured using non-stretch measuring tape to the nearest 0.1 cm with %CV of 0.17 and 0.13%, respectively. Weight class was created as normal weight (BMI ˂ 25 kg m −2 ), overweight (BMI 25-30 kg m −2 ), and obese (BMI > 30 kg m −2 ). Blood samples were collected by venepuncture by trained phlebotomists and stored appropriately until they reached the lab within 5 h of collection for processing and further storage at −80°C until further analysis. Biochemical values were assessed using a clinical bioanalyzer (Randox Daytona, www.advancedsciencenews.com www.mnf-journal.com Randox Laboratories) and cytokines and hormones using a biochip array system (Evidence Investigator, Randox Laboratories) except adiponectin which was measured by ELISA (ALPCO Diagnostics Kit). All samples were run in duplicate with standard quality control procedures followed in both analyses to ensure data integrity. HOMA-insulin resistance (HOMA-IR) score was calculated using the formula (fasting insulin μU mL
× fasting glucose mmol L −1 )/22.5. [25] Quantitative sensitivity check index score was calculated as follows: 1/(log(fasting insulin μU mL −1 ) + log(fasting glucose mg dL −1 ). [26] Diagnosis of MetS was defined according to the National Cholesterol Education Programme's Adult Treatment Panel III criteria for MetS 2001 [27] including fasting blood glucose concentrations of 5.5-
(women), blood pressure ࣙ130/85 mmHg, and waist circumference >102 cm (men) and >88 cm (women). Physical activity was estimated using a tri-axial accelerometer (Actigraph GT1M, ActiGraph, LLC) for the 4 days of the survey period.
[28]
Genotyping
Fifteen single nucleotide polymorphisms (SNPs) were selected based on previous studies which have been shown to be associated with circulating LA [14] [15] [16] and human health. [29] SNP genotyping was then conducted by the LGC group (www.lgcgroup.com) using their proprietary KASPar PCR technique. [30] 
Statistical Analysis
Plasma n-6 PUFA (18:2n-6, 18:3n-6, 20:2n-6, 20:3n-6, 20:4n-6, 22:4n-6) profiles were compared across normal weight, overweight, and obese participants. Quartiles of plasma LA, GLA, and DGLA were obtained using SPSS version 20.0 (IBM Inc. Chicago, USA). General linear contrast model adjusted for age, body fat, blood pressure, waist circumference, waist hip ratio, smoking status, working energy expenditure, and BMI was applied across plasma LA quartiles for comparison of percentage of plasma fatty acid, nutrient density (calculated as % total energy (TE) or μg or mg/10 MJ), and circulating concentrations of biochemical biomarkers. Differences in gender, social class, smoking habits, contraceptive use, and metabolic risk factors across quartiles were compared using Chi-square test. -5-Desaturase (D5D) and -6-desaturase (D6D) were estimated using fatty acid product/precursor ratios as following: D6D = C18:3n-6/C18:2n-6 and D5D = C20:4n-6/C20:3n-6. [31] Contraceptive use in females was not controlled for in subsequent analysis due to the low proportion (3.5%) of oral contraceptive users in the NANS with no difference in proportions across LA quartiles (p = 0.094). Oneway analysis of variance was also applied across fatty acid clusters for demographic variables including age, BMI, waist circumference, body fat physical activity, waist hip ratio, and blood pressure. Skewed data were log transformed to obtain normalized distribution. Where appropriate in this exploratory analysis, Bonferroni correction was applied by adjusting the p-values by the number of traits in each table. p-Values that exceed 1.0 after correction for multiple testing have been marked down to 1.000.
Linkage disequilibrium (LD) was assessed using Haploview 4.2, [32] and haplotype blocks were obtained using the Gabriel's definition. [33] Haplotype frequency was estimated using Haplo.Stat 1.7.6 package in R 3.2 (R Foundation for Statistical Computing, Vienna, Austria; ISBN 3-900051-07-0; Internet: http://www.R-project.org). Multiple linear regression with stepwise backward selection was used to explore possible determinants of plasma LA status. Demographic and dietary intake variables were included in the initial model and haplotypes were included in the final model regardless of the significance. Partial R 2 was used to calculate the explained variation of each determinants in the final model. The association between plasma LA and haplotypes were estimated using HapStat 3.0. [34] 
Results
A complete fasting plasma fatty acid dataset of 820 participants (mean age 41.9 ± 16.7 years, with 412 males and 408 females) were included in the analysis. Initial examination showed that plasma LA and estimated -5-desaturase activity decreased while GLA, DGLA, and -6-desaturase activity increased across the body weight categories in Irish adults (p ࣘ 0.003) ( Table 1) . Demographics and markers of metabolic health were compared across the quartiles of plasma LA (Tables 2 and 3) , GLA, and DGLA (Supporting Information Table S1 ) to explore any association between plasma LA, GLA, DGLA, and health parameters. As quartiles of plasma LA showed greater separation in terms of demographics and markers of metabolic health (as described below) therefore subsequent analysis focused on plasma LA only.
Demographics and Dietary Intakes
As shown in Table 2 , participants in the highest quartile of plasma LA displayed a healthier phenotype. Compared with participants in quartile 1 (Q1), participants in quartile 4 (Q4) were younger (50.7 vs 36.5 years, p < 1.9 × 10 −19 ), with lower adiposity (including BMI, body fat, waist circumference, and waist hip ratio, p < 3. Table S2 . Across plasma LA quartiles, intake of starch, PUFA, n-6 PUFA, and dietary fiber significantly increased (p < 0.003).
Markers of Metabolic Health and Plasma Fatty Acids
The clinical chemistry biomarkers and plasma fatty acid levels across quartiles are shown in Table 3 . After adjustment for confounders, insulin, C-peptide, TAG, HOMA-IR, PAI-1, TNF-α, www.advancedsciencenews.com www.mnf-journal.com Table 1 . Profile of plasma n-6 fatty acids among normal weight, overweight, and obese Irish adults (n = 781). Participants who are under-weight (n = 5) and participants with missing BMI value were excluded from this analysis (n = 34 and high-sensitivity-C-reactive protein (hs-CRP) decreased, while quantitative sensitivity check index and adiponectin increased across plasma LA quartiles (p ࣘ 0.005). Regarding plasma fatty acids related to the n-6 PUFA pathway, 20:2n-6, 18:3n-6, 20:3n-6, and D6D decreased across plasma LA quartiles (p ࣘ 0.019), whereas total n-6 PUFA and n-6/n-3 ratio increased (p ࣘ 1.4 × 10 −138 ). Plasma total saturated fatty acid and total MUFA decreased (p ࣘ 1.1 × 10 −21 ), as did plasma fatty acids related to de novo lipogenesis (DNL, including 14:0, 14:1n-5, 16:0, 16:1n-7, and 18:1n-9) were also significantly decreased (p ࣘ 4.7 × 10 −6 ) across plasma LA quartiles.
Effects of Haplotypes on Plasma n-6 PUFA Profiles
The degree of linkage disequilibrium between the analyzed genetic polymorphisms is shown in Supporting Information Figure S1 . Haplotypes were statistically reconstructed for three windows ( Table 4 ). The first window contained all 15 SNPs from rs174537 to rs482548. Seven haplotypes were identified in this window with a frequency over 1%, of which haplo 7 was the most common (53.9%) haplotype with no minor allele. Compared with haplo 7, haplo 1, 3, 4, 5 were positively associated with plasma LA (p ࣘ 0.02), with all of the haplotypes except haplo 2 negatively associated with D5D and D6D (p ࣘ 6.44 × 10 −3 ) ( Table 5 ). The second window contained eight SNPs from rs174537 to rs99780, and four haplotypes were reconstructed with frequency above 1%. Compared with the most common haplotype (haplo 4 with frequency of 65.6%) in the second window, all the other haplotypes were positively associated with plasma LA while negatively associated with D5D and D6D (p ࣘ 1.67 × 10 −3 ). The third window contained three SNPs from rs2524299 to rs174583, and three haplotypes were reconstructed with a frequency above 1%. Compared with the most common haplotype (haplo 3 with frequency of 65.5%) in the third window, all of the other haplotypes were positively associated with plasma LA while negatively associated with D5D and D6D (p ࣘ 1.64 × 10 −3 ). Haplotypes in the second and third windows explained the variance of plasma LA by 3.5%, respectively (Supporting Information Tables S2 and S4 ). We also explored the interaction of dietary PUFA intakes and haplotypes but no significant interaction was found after adjustment for confounders (p ࣙ 0.057).
Possible Determinants of Plasma LA
Multiple linear regressions of possible determinants of plasma LA are shown in Table 6 . Of the variables tested, adiposity measures (waist circumference and body fat) were most strongly inversely associated with plasma LA accounting for 11.8% of the total variance, followed by 15-SNP haplotypes (3.9%), quantity and quality of carbohydrate intakes (3.8%), dietary PUFA intakes (3.7%), systolic blood pressure (3.6%), and age (3.2%).
Discussion
In this study, higher plasma LA was related to a healthier phenotype and metabolic profile in Irish adults. We observed an inverse relationship between plasma LA and the adiposity measures studied, with waist circumference and body fat most strongly associated with plasma LA, followed by dietary PUFA and haplotypes of FADS genes. The beneficial effects of plasma LA may be associated with decreased biomarkers of DNL, insulin resistance, and inflammation, all of which have previously been linked with the pathogenesis of obesity. [35, 36] A growing body of evidence suggests that LA may influence health outcomes. An inverse relationship between serum LA and all-cause mortality (but not CVD risk) has been described in a cohort of healthy older adults. [37] Further observational studies report lower plasma phospholipid LA and higher GLA and DGLA levels in overweight/obese adolescents [9, 38] and higher proportions of serum and cholesterol ester LA being associated with lower markers of abdominal obesity and BMI and reduced type 2 diabetes (T2D) incidence. [8, [39] [40] [41] Altered desaturase activity is documented in overweight and obese participants and those with www.advancedsciencenews.com www.mnf-journal.com T2D, with reports of elevated D6D and decreased D5D. [8, 9, 38, 40] Growing evidence suggests that such benefits may arise from effects of LA on body fat accumulation. Animal trials and human randomized control trials indicate that compared to saturated fatty acid, high LA intakes result in improvements in body composition outcomes. [4, 5, 42] There is some evidence of similar benefits in populations with regular dietary LA intakes whereby serum or erythrocyte LA was inversely related to body fat, specifically trunk fat in a healthy elderly cohort [5] and in a middle aged relatively healthy cohort. [11] Of interest, such benefits were not observed for erythrocyte n-3 PUFA or for the MUFA, oleic acid (OA). [11] In the present study, we confirm these fatty acid profiles of elevated LA and altered patterns of D5D and D6D activity according to body weight status and without significant alterations in n-3 PUFA status, in this nationally representative cohort of healthy adults aged 18-90 years. Our study adds to evidence which is suggestive of either a protective effect of circulating LA on obesity and/or of altered fatty acid metabolism in the presence of excess body weight. However, desaturase activities based on ratio of circulating fatty acids are indirect measure of enzyme activities which may also be affected by lifestyle. Further, our results are presented as percentage, rather than absolute, values which may imply codependence on all other fatty acids. Further research is required to explore the specific health implications of plasma LA as well as any interactions between dietary PUFA intakes and circulating fatty acid profiles.
www.advancedsciencenews.com www.mnf-journal.com Table 3 . Concentration of biochemistry biomarkers across quartiles of plasma linoleic acid in Irish adults (n = 820). Comparisons of concentration of biochemical biomarkers and plasma fatty acids (log transformed for skewed variable) across quartiles were assessed using general linear contrast model adjusted for age, body fat, blood pressure, waist circumference, waist hip ratio, smoking status, working energy expenditure, and BMI. p-Values were corrected by multiple number of traits. p-Values that exceed 1.0 after correction for multiple testing have been marked down to 1.000. QUICKI, quantitative insulin sensitivity check index; PAI-1, plasminogen activator inhibitor-1; hs-CRP, high-sensitivity-C-reactive protein; D5D, delta-5-desaturase (20:4n6/20:3n6); D6D, delta-6-desaturase (18:3n6/18:2n6).
www.advancedsciencenews.com www.mnf-journal.com Previous studies have demonstrated a similar inverse association between circulating LA and biomarkers such as insulin, glucose, TAG, hs-CRP, with higher adiponectin concentrations and with reduced risk of insulin resistance, metabolic syndrome, cardio-metabolic risk score and T2D. [5, [8] [9] [10] [43] [44] [45] In addition, our results show decreased inflammation markers such as PAI-1 and TNF-α across plasma LA quartiles, elevated levels of which have been linked to obesity. [46] Nevertheless, this decrease in markers of metabolic health in the present study remained significant even when controlling for BMI and waist circumference. A negative association between plasma LA and inflammation markers, e.g., IL-6 and CRP has been reported elsewhere. [11, 47] Such associations may be explained by a recent study, showing that LA may suppress the expression of toll-like receptor 4, phosphorylation levels of c-Jun amino-terminal kinases and agouti-related protein. [48] Agouti-related protein promotes food intake, [49] and an absence of c-Jun amino-terminal kinase-1 may lead to decreased adiposity and improved insulin sensitivity. [50] Such potential mechanisms may help explain the decreased adiposity and markers of inflammation observed in participants in the highest quartile of plasma LA (Q4). Moreover, bioactive metabolites of LA such as nitro-linoleic acid may be anti-inflammatory by reducing the activation and gene transcription of nuclear factor-κB while stimulating activation of peroxisome proliferator-activated receptor-γ . [51] Further research is required in this area. It is possible that the decreased plasma LA observed in overweight/obese participants in our study may be linked to DNL. DNL is a, typically inhibited, pathway of converting excess carbohydrate to esterified fatty acids which are subsequently stored as TAG in the liver and adipose tissue. [52] Increased DNL has been observed in the obese, [35, 53] in nonalcoholic fatty liver disease, [54] and under conditions of insulin resistance, including inflammation. [52] Further, DNL stimulated hepatic TAG are reported to be enriched with palmitic acid while depleted in LA. [55] In our study, in addition to decreased levels of plasma LA observed in obese participants, all adults in the lowest quartile of plasma LA had a fatty acid profile suggestive of DNL (i.e., reduced LA and increased 14:0, 16:0, and 16:1n-7) and with patterns of Table 5 . Estimates of haplotypes effects on plasma linoleic acid, -5 desaturase and -6 desaturase (n = 790). The most common haplotype was used as reference. Maximum likelihood estimation adjusted for age, BMI, body fat, waist circumference, working energy expenditure, waist hip ratio, blood pressure, and smoking habits was used. biochemical markers suggestive of insulin resistance and lowgrade inflammation. Dietary intakes may also influence DNL, whereby high carbohydrate, low fat diets may promote DNL, particularly when dietary sugar is substituted for starch. [56] In contrast, high dietary fibre intakes can yield less SCFAs, which may suppress DNL and improve insulin sensitivity. [57, 58] In our study, participants had a relatively high fat diet (mean daily intake of 33.8% TE) and moderate carbohydrate intakes (mean daily intake of 42.6% TE). Nevertheless, participants with the lowest circulating plasma concentrations (quartile 1) had lower intakes of starch and dietary fibre, while regression analysis identified quantity and quality of carbohydrate intake as the third largest determinant of plasma LA (3.8%). Collectively, in this cohort of generally healthy adults, there exists a group with lipid and metabolic profiles suggestive of possible future risk and who can be easily identified by nature of circulating plasma LA concentrations. This is supportive of the hypothesis which aims to clarify whether endogenous metabolites or lipids constitute simple and effective biomarkers of metabolic diseases such as NAFLD, T2D, and metabolic syndrome. [6, 54] Polymorphism and haplotype of FADS1/2 genes have been reported to be linked to long-chain PUFA concentrations/metabolism such as for LA, ARA, D5D, and D6D. [14, 29, 59, 60] To our knowledge, only one study reported variation of haplotypes of FADS genes in relation to serum phospholipid, which was higher compared with the present study (9.2 vs 3.9%). [14] This may due to different SNPs, lipid fractions and study population included. Potential dietary PUFA intakes × haplotypes interactions were also explored in the present study, however, the p-values were above the significant threshold (p ࣙ 0.057) after adjustment for confounders. [61] The impact of dietary intakes × haplotypes/genotype interactions on circulating n-6 PUFA profiles have been poorly explored and merits future study. [62] Haplotype analysis of FADS genes also revealed significant association between haplotypes and concentration of hs-CRP and TAG. [15, 16] Similarly, results of genome-wide association studies reported that carriers of the minor allele of rs174537 and rs174547 showed lower total cholesterol HDLcholesterol and LDL-cholesterol. [63, 64] However, no significant association was identified in our study between haplotypes and inflammation markers, suggesting that haplotype may not be involved in the association between plasma LA and inflammation.
Mol
The major strength of the present study is that we included a comprehensive group of inflammation markers, genotype information, as well as the combination of dietary and plasma fatty acid data which clearly showed the beneficial effects of a higher plasma LA. Limitations of the study include the observational study design that is unable to reveal the causality of the relations. In this national food consumption survey (NANS), body composition measurements were collected by trained field workers with body fat assessed using a Tanita body fat analyzer rather than gold standard methods such as MRI, computed tomography, or dual energy x-ray absorpiometry (DEXA) scans. This was due to the practical simplicity of using Tanita as part of a national food consumption survey. It has been reported that Tanita is not associated with a clinically significant decrement in performance relative to traditional impedence devices, [65] although it is recognized that this technique may slightly overestimate fat mass relative to DEXA [66] and MRI. [67] A further limitation of this study was the use of total plasma fatty acids rather than lipid fractions given that different associations have been reported between phospholipid and cholesterol esters. [68] Finally, we acknowledge that alterations in proportions of circulating fatty acids with age are well described, with reductions in erythrocyte concentrations of linoleic acid reported to be in the order of two percentage points per decade. [69] In our study, those in the lowest quartile of plasma LA were older than those in the highest quartile. Hence, it is possible that age-related influences on body fat accumulation and on metabolic health may have influenced outcome. However, we controlled for age in all relevant analysis to attempt mitigate any such risk.
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In conclusion, our results showed that plasma LA was inversely associated with adiposity, followed by haplotype of FADS genes and dietary intakes. A higher plasma LA profile was related to a healthier phenotype and markers of metabolic health even when controlling for BMI and waist circumference. Future work is needed to better understand the mechanism of obesity modified plasma LA profile on human health.
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